153 related articles for article (PubMed ID: 35709702)
21. Tumor-infiltrating mast cells stimulate ICOS
Lv Y; Tian W; Teng Y; Wang P; Zhao Y; Li Z; Tang S; Chen W; Xie R; Lü M; Zhuang Y
J Adv Res; 2024 Mar; 57():149-162. PubMed ID: 37086778
[TBL] [Abstract][Full Text] [Related]
22. Hepatocellular carcinoma and macrophage interaction induced tumor immunosuppression via Treg requires TLR4 signaling.
Yang J; Zhang JX; Wang H; Wang GL; Hu QG; Zheng QC
World J Gastroenterol; 2012 Jun; 18(23):2938-47. PubMed ID: 22736917
[TBL] [Abstract][Full Text] [Related]
23. Clinical prognostic value of CD4+CD25+FOXP3+regulatory T cells in peripheral blood of Barcelona Clinic Liver Cancer (BCLC) stage B hepatocellular carcinoma patients.
Li F; Guo Z; Lizée G; Yu H; Wang H; Si T
Clin Chem Lab Med; 2014 Sep; 52(9):1357-65. PubMed ID: 24646790
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive Analysis of the Immunosuppressive Function of Regulatory T Cells in Human Hepatocellular Carcinoma Tissues.
Ge J; Chen J; Shen Q; Zheng X; Chen X; Shi L; Chen L; Xu B
Cancer Control; 2024; 31():10732748241251580. PubMed ID: 38712609
[TBL] [Abstract][Full Text] [Related]
25. Investigation of
Yang J; Liu J; Chen Y; Tang W; Bo K; Sun Y; Chen J
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31235485
[TBL] [Abstract][Full Text] [Related]
26. Prediction of recurrence and survival in hepatocellular carcinoma based on two Cox models mainly determined by FoxP3+ regulatory T cells.
Lin SZ; Chen KJ; Xu ZY; Chen H; Zhou L; Xie HY; Zheng SS
Cancer Prev Res (Phila); 2013 Jun; 6(6):594-602. PubMed ID: 23599540
[TBL] [Abstract][Full Text] [Related]
27. Regulatory T cells and plasmacytoid dendritic cells contribute to the immune escape of papillary thyroid cancer coexisting with multinodular non-toxic goiter.
Yu H; Huang X; Liu X; Jin H; Zhang G; Zhang Q; Yu J
Endocrine; 2013 Aug; 44(1):172-81. PubMed ID: 23264145
[TBL] [Abstract][Full Text] [Related]
28. Role of Foxp3-positive tumor-infiltrating lymphocytes in the histologic features and clinical outcomes of hepatocellular carcinoma.
Mathai AM; Kapadia MJ; Alexander J; Kernochan LE; Swanson PE; Yeh MM
Am J Surg Pathol; 2012 Jul; 36(7):980-6. PubMed ID: 22446942
[TBL] [Abstract][Full Text] [Related]
29. Pulmonary sarcoidosis is associated with high-level inducible co-stimulator (ICOS) expression on lung regulatory T cells--possible implications for the ICOS/ICOS-ligand axis in disease course and resolution.
Sakthivel P; Grunewald J; Eklund A; Bruder D; Wahlström J
Clin Exp Immunol; 2016 Feb; 183(2):294-306. PubMed ID: 26415669
[TBL] [Abstract][Full Text] [Related]
30. Acute Myeloid Leukemia Cells Express ICOS Ligand to Promote the Expansion of Regulatory T Cells.
Han Y; Dong Y; Yang Q; Xu W; Jiang S; Yu Z; Yu K; Zhang S
Front Immunol; 2018; 9():2227. PubMed ID: 30319662
[TBL] [Abstract][Full Text] [Related]
31. IL-33 in the tumor microenvironment is associated with the accumulation of FoxP3-positive regulatory T cells in human esophageal carcinomas.
Cui G; Li Z; Ren J; Yuan A
Virchows Arch; 2019 Nov; 475(5):579-586. PubMed ID: 31062086
[TBL] [Abstract][Full Text] [Related]
32. Cutting Edge: ICOS-Deficient Regulatory T Cells Display Normal Induction of
Landuyt AE; Klocke BJ; Colvin TB; Schoeb TR; Maynard CL
J Immunol; 2019 Feb; 202(4):1039-1044. PubMed ID: 30642977
[TBL] [Abstract][Full Text] [Related]
33. ICOS-deficient and ICOS YF mutant mice fail to control Toxoplasma gondii infection of the brain.
O'Brien CA; Harris TH
PLoS One; 2020; 15(1):e0228251. PubMed ID: 31978191
[TBL] [Abstract][Full Text] [Related]
34. The role of FoxP3+ regulatory T cells and IDO+ immune and tumor cells in malignant melanoma - an immunohistochemical study.
Salmi S; Lin A; Hirschovits-Gerz B; Valkonen M; Aaltonen N; Sironen R; Siiskonen H; Pasonen-Seppänen S
BMC Cancer; 2021 May; 21(1):641. PubMed ID: 34051744
[TBL] [Abstract][Full Text] [Related]
35. CD4
Chauhan R; Awasthi V; Thakur RS; Pande V; Chattopadhyay D; Das J
Malar J; 2022 Feb; 21(1):32. PubMed ID: 35109868
[TBL] [Abstract][Full Text] [Related]
36. Special role of Foxp3 for the specifically altered microRNAs in Regulatory T cells of HCC patients.
Chen L; Ma H; Hu H; Gao L; Wang X; Ma J; Gao Q; Liu B; Zhou G; Liang C
BMC Cancer; 2014 Jul; 14():489. PubMed ID: 25000974
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of CD39 in hepatocellular carcinoma is an independent indicator of poor outcome after radical resection.
Cai XY; Ni XC; Yi Y; He HW; Wang JX; Fu YP; Sun J; Zhou J; Cheng YF; Jin JJ; Fan J; Qiu SJ
Medicine (Baltimore); 2016 Oct; 95(40):e4989. PubMed ID: 27749555
[TBL] [Abstract][Full Text] [Related]
38. FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis.
Kobayashi N; Hiraoka N; Yamagami W; Ojima H; Kanai Y; Kosuge T; Nakajima A; Hirohashi S
Clin Cancer Res; 2007 Feb; 13(3):902-11. PubMed ID: 17289884
[TBL] [Abstract][Full Text] [Related]
39. An Antibody Targeting ICOS Increases Intratumoral Cytotoxic to Regulatory T-cell Ratio and Induces Tumor Regression.
Sainson RCA; Thotakura AK; Kosmac M; Borhis G; Parveen N; Kimber R; Carvalho J; Henderson SJ; Pryke KL; Okell T; O'Leary S; Ball S; Van Krinks C; Gamand L; Taggart E; Pring EJ; Ali H; Craig H; Wong VWY; Liang Q; Rowlands RJ; Lecointre M; Campbell J; Kirby I; Melvin D; Germaschewski V; Oelmann E; Quaratino S; McCourt M
Cancer Immunol Res; 2020 Dec; 8(12):1568-1582. PubMed ID: 32999002
[TBL] [Abstract][Full Text] [Related]
40. Impairment of CD4+ cytotoxic T cells predicts poor survival and high recurrence rates in patients with hepatocellular carcinoma.
Fu J; Zhang Z; Zhou L; Qi Z; Xing S; Lv J; Shi J; Fu B; Liu Z; Zhang JY; Jin L; Zhao Y; Lau GK; Zhao J; Wang FS
Hepatology; 2013 Jul; 58(1):139-49. PubMed ID: 22961630
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
